脑部放疗，上午比下午敏感许多！4 [4 B3 C9 u% Y1 p. Y2 s/ v
# b. `: Z" a7 }$ H0 t- y6 ?! M
! K# q0 h2 V- \
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
1 i8 c' h. M, D5 a2 v) }( ?Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
5 b/ z! ?0 V+ V$ I) u% P5 |6 TRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T." C" L9 j7 ]# d
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
) ^, I2 F; O$ G1 [ p
* w: O/ P/ Q e% [+ UAbstract" ]6 Y4 ?) {# K( ]1 W; n2 s& v7 F
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.) [7 ], ], j3 _2 C& L1 u/ G" J2 W, U
: Z) c+ h% }# K0 B9 U/ @' ~
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.' r' W8 I# M0 G" ?% x$ n
, X/ u- V" J7 a4 J
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)." J ^4 O3 @0 m! ]1 Z; a
) C6 _5 w& S x) l/ C4 ACONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
8 h! P/ k% f6 z6 b$ Q2 V
% F6 j5 s! H- W. ^$ D |
- m% ^7 v7 t. o9 G- k" W% V
显身卡
